Harvard Bioscience (HBIO) Competitors

Harvard Bioscience (NASDAQ:HBIO) and Thermo Fisher Scientific (NYSE:TMO) are both life sciences tools & services companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Which has stronger earnings and valuation, HBIO or TMO?

Thermo Fisher Scientific has higher revenue and earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harvard Bioscience	$94.14M	0.21	-$12.40M	-$1.32	-0.34
Thermo Fisher Scientific	$42.88B	3.83	$6.34B	$17.05	25.51

Do insiders & institutionals hold more shares of HBIO or TMO?

80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 9.5% of Harvard Bioscience shares are owned by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the media favor HBIO or TMO?

In the previous week, Thermo Fisher Scientific had 49 more articles in the media than Harvard Bioscience. MarketBeat recorded 70 mentions for Thermo Fisher Scientific and 21 mentions for Harvard Bioscience. Thermo Fisher Scientific's average media sentiment score of 1.14 beat Harvard Bioscience's score of -0.21 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Harvard Bioscience	0 Very Positive mention(s)	1 Positive mention(s)	11 Neutral mention(s)	7 Negative mention(s)	1 Very Negative mention(s)	Neutral
Thermo Fisher Scientific	47 Very Positive mention(s)	6 Positive mention(s)	8 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive

Do analysts rate HBIO or TMO?

Harvard Bioscience currently has a consensus target price of $3.00, indicating a potential upside of 574.61%. Thermo Fisher Scientific has a consensus target price of $600.30, indicating a potential upside of 37.99%. Given Harvard Bioscience's higher possible upside, equities analysts clearly believe Harvard Bioscience is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harvard Bioscience	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.80

Which has more risk and volatility, HBIO or TMO?

Harvard Bioscience has a beta of 1.52, indicating that its stock price is 52% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, indicating that its stock price is 23% less volatile than the S&P 500.

Is HBIO or TMO more profitable?

Thermo Fisher Scientific has a net margin of 15.19% compared to Harvard Bioscience's net margin of -63.51%. Thermo Fisher Scientific's return on equity of 17.15% beat Harvard Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Harvard Bioscience	-63.51%	-4.96%	-2.24%
Thermo Fisher Scientific	15.19%	17.15%	8.47%

Summary

Thermo Fisher Scientific beats Harvard Bioscience on 13 of the 16 factors compared between the two stocks.